MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Shockwave Medical raises $40 million for its ‘lithoplasty’ system | Medtech funding for the week of May 18, 2015

Shockwave Medical raises $40 million for its ‘lithoplasty’ system | Medtech funding for the week of May 18, 2015

By

PAD: Shockwave Medical raises $40M

May 19, 2015 by Fink Densford

PAD: Shockwave Medical raises $40M

Shockwave Medical announced $40 million in funding for its novel balloon catheter designed to treat calcified lesions in the peripheral vasculature.

Investors include prior backer Sofinnova Partners and newcomer Venrock, as well as RA Capital, Deerfield, Sectoral Asset Management, Ally Bridge group and 2 undisclosed large-cap investors, Fremont, Calif.-based Shockwave said. Read more

PAD: Intact Vascular raises $39m for Tack device

May 15, 2015 by Brad Perriello

PAD: Intact Vascular raises $39m for Tack device

Intact Vascular said it brought in a $38.9 million Series B round it plans to use to get its Tack endovascular device through the FDA approval process.

Wayne, Pa.-based Intact said the round was led by New Enterprise Assoc. and included Quaker Partners, H.I.G. BioVentures and other prior backers. NEA director Dr. Justin Klein is slated to join the company’s board as part of the round, Intact said. Read more

ConvaTec plans $1.9B refi

May 18, 2015 by Mark Hollmer

ConvaTec plans $1.9B refi

ConvaTec, which just named a new CEO and is rumored to be up for sale, plans to raise nearly $1.9 billion in loan and credit facilities in a debt-refinancing move.

The Luxembourg-based medical device company will seek $1.65 billion in term loan facilities and a $200 million revolving credit facility, both due in 2020. Plans call for using the money to refinance existing credit facilities and senior secured notes, the company said. Read more

Outset Medical raises $60m for home dialysis device

May 20, 2015 by Fink Densford

Outset Medical raises $60m for home dialysis device

Outset Medical, previously Home Dialysis Plus, said it raised $60 million from 9 unnamed investors as it prepares to go head to head with NxStage Medical on the home hemodialysis front.

Outset touts its new device, the Tablo, as the 1st dialysis machine designed as a consumer product, according to Warburg Pincus. The Vertical Group is also an investor, according to Outset’s website. Read more

Smith & Nephew gets in on OrthoSpace round

May 21, 2015 by Fink Densford

OrthoSpace completes financing for InSpace rotator cuff treatment

OthoSpace said this week that it completed “significant” but unspecified financing for its InSpace biodegradable orthopedic balloon, led by Healthpoint Capital with participation from Smith & Nephew and Triventures.

The InSpace device is a minimally invasive orthopedic balloon designed for use in rotator cuff repairs. Read more

In case you missed it

RSS From Medical Design & Outsourcing

  • Lifecore Biomedical’s owner plans to go all-in on contract development and manufacturing
    Lifecore Biomedical parent company Landec Corp. (Nasdaq:LNDC) plans to take the subsidiary’s name, leadership and headquarters as its own and sell off food businesses to focus on contract development and manufacturing. Santa Maria, California-based Landec said it will rename itself as Lifecore Biomedical “in the near future” and change its Nasdaq ticker to LFCR. Landec… […]
  • COVID-19 immunity test developers at MIT seek diagnostic manufacturer
    MIT researchers have developed a device for predicting an individual’s COVID-19 immunity and are looking for a diagnostic company to get it manufactured in large numbers and approved by the FDA. The lateral flow test uses the same technology as at-home rapid antigen COVID-19 tests to measure neutralizing antibodies for SARS-CoV-2 in a blood sample,… […]
  • GE Healthcare picks AI imaging startups for inaugural Edison Accelerator
    GE Healthcare and Nex Cubed have selected seven companies focused on artificial-intelligence-augmented medical imaging for the first cohort of the Edison Accelerator in Canada. The companies will be matched with mentors and test their technologies with GE’s new Edison Digital Health Platform over the next three months. The program will end with innovation showcase presentations… […]
  • Boston Scientific whistleblower launches corruption investigation
    Boston Scientific (NYSE:BSX) is investigating claims that the company violated the U.S. Foreign Corrupt Practices Act in Vietnam. Marlborough, Massachusetts–based Boston Scientific disclosed receipt of a whistleblower’s allegations in its latest filing with the Securities and Exchange Commission. “In March 2022, the company received a whistleblower letter alleging Foreign Corrupt Practices Act violations in Vietnam.… […]
  • 5 essential leadership lessons from Cathy Burzik for medtech’s next generation of women leaders
    Cathy Burzik, a seasoned senior executive in the healthcare industry, has successfully led major medical device, diagnostic, diagnostic imaging and life sciences businesses. Cathy Burzik, CFB Interests (as told to MedExecWomen co-founder Maria Shepherd) One key to being a successful women leader in MedTech: “Play nice, but play to win.” Cathy Burzik, who received a… […]
  • Stratasys plans to buy Covestro’s additive manufacturing business
    Stratasys (Nasdaq:SSYS) said today that it has a deal to purchase the additive manufacturing materials business of Covestro. The deal includes R&D facilities and activities, global development and sales teams across Europe, the U.S. and China, a portfolio of approximately 60 additive manufacturing materials, and hundreds of patents and patents pending, Stratasys said in a… […]
  • New implant design prevents scar tissue without drugs, MIT says
    Mechanically inflating and deflating an implantable device for 10 minutes a day prevents immune cells from building the scar tissue that has been a major obstacle for artificial pancreas researchers. That’s according to new findings from a team of MIT engineers who built mechanical deflection into a two-chambered, soft polyurethane device tested on mice. By… […]
  • Blue Spark’s TempTraq catches fevers faster. Fever prediction is next.
    Blue Spark Technologies developed the first wireless continuous temperature monitor patch, TempTraq, to enable faster fever detection than standard manual readings every four hours. Westlake, Ohio-based Blue Spark is now looking at fever prediction rather than just detecting them. The R&D team is working on developing an AI neural network model built on the company’s… […]
  • Harvard researchers plan to sell at-home, PCR-grade COVID testing system
    The Harvard University researchers who developed an ultrasensitive, PCR-grade nucleic acid detection technology plan to commercialize it as a portable COVID-19 test. Harvard Medical School professor Peng Yin, who also leads the Wyss Institute for Biologically Inspired Engineering’s Molecular Robotics Initiative, founded 3EO Health to sell the device. “In order to optimize the value of… […]
  • FDA reports sterilization challenge progress as EPA takes aim at EtO emissions
    The FDA offered an update on its efforts to make medical device sterilization safer as the EPA identified 23 U.S. facilities where use of ethylene oxide (EtO) presents a risk to communities. The FDA said it is similarly concerned about unsafe EtO emissions and highlighted work with the medical device industry to reduce EtO usage… […]
  • AdvaMed defends EtO facilities on EPA’s cancer risk list
    The Advanced Medical Technology Association (AdvaMed) today reacted to the EPA’s listing of commercial sterilization facilities causing elevated risks of cancer with a defense of the facilities and a call for more research. AdvaMed CEO and President Scott Whitaker said all of the listed facilities are in compliance with regulations and warned against closures. “The… […]

Leave a Reply